Literature DB >> 17171398

Importance of luxury flow for critically ill patients receiving a left ventricular assist system.

Motonobu Nishimura1, Takashi Nishimura, Masayuki Ishikawa, Ayumu Masuoka, Nobuyuki Okamura, Keiko Abe, Takahiro Matsuoka, Mika Iwazaki, Kazuhito Imanaka, Haruhiko Asano, Shunei Kyo.   

Abstract

The presence of a significant organ dysfunction does not immediately exclude patients from consideration for treatment with a left ventricular assist system (LVAS). However, in treating morbid circulatory shock patients with multiple organ failure, it is important to know the preoperative and postoperative factor or factors related to the recovery of the damaged organ function. In this study, we retrospectively analyzed patients receiving a LVAS at our institution and tried to determine the important factors related to the survival of patients with multisystem failure. Twenty-seven patients who underwent LVAS placement at Saitama Medical School Hospital between 1993 and 2003 were included in this study. The preoperative risk factors analyzed were renal dysfunction, respiratory dysfunction, hepatic dysfunction, the existence of active infection, and the combination of all four factors. As a postoperative factor, the pump flow index (mean LVAS pump flow during the first 2 weeks after LVAS surgery divided by the body surface area) was analyzed. None of the analyzed preoperative factors could predict survival after LVAS surgery, but a pump flow index of less than 2.5 l/min/m2 had a significant relationship with death after LVAS surgery. Further analysis revealed that all the patients with a pump flow index of 3.0 l/min/m2 or more could overcome preoperative organ dysfunction. Congestive heart failure patients with multisystem failure need luxury pump flow for successful LVAS surgery; this factor could be especially important in device selection and postoperative management.

Entities:  

Mesh:

Year:  2006        PMID: 17171398     DOI: 10.1007/s10047-006-0355-y

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  13 in total

Review 1.  Mechanical circulatory support and cardiac transplantation.

Authors:  S A Hunt; O H Frazier
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

2.  One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology.

Authors:  P M McCarthy; N O Smedira; R L Vargo; M Goormastic; R E Hobbs; R C Starling; J B Young
Journal:  J Thorac Cardiovasc Surg       Date:  1998-04       Impact factor: 5.209

3.  Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation.

Authors:  Takafumi Masai; Yoshiki Sawa; Shigeaki Ohtake; Toshirou Nishida; Motonobu Nishimura; Norihide Fukushima; Takashi Yamaguchi; Hikaru Matsuda
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

4.  Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome.

Authors:  M C Deng; M Loebe; A El-Banayosy; E Gronda; P G Jansen; M Vigano; G M Wieselthaler; B Reichart; E Vitali; A Pavie; T Mesana; D Y Loisance; D R Wheeldon; P M Portner
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

Review 5.  Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation.

Authors:  F A Arabia; R G Smith; D S Rose; D A Arzouman; G K Sethi; J G Copeland
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

6.  Eight years' experience with bridging to cardiac transplantation.

Authors:  D G Pennington; L R McBride; P S Peigh; L W Miller; M T Swartz
Journal:  J Thorac Cardiovasc Surg       Date:  1994-02       Impact factor: 5.209

7.  Revised screening scale to predict survival after insertion of a left ventricular assist device.

Authors:  Vivek Rao; Mehmet C Oz; Margaret A Flannery; Katharine A Catanese; Michael Argenziano; Yoshifumi Naka
Journal:  J Thorac Cardiovasc Surg       Date:  2003-04       Impact factor: 5.209

8.  Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices.

Authors:  M C Oz; D J Goldstein; P Pepino; A D Weinberg; S M Thompson; K A Catanese; R L Vargo; P M McCarthy; E A Rose; H R Levin
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

9.  Improved survival after extended bridge to cardiac transplantation.

Authors:  O H Frazier; M P Macris; T J Myers; J M Duncan; B Radovancević; S M Parnis; D A Cooley
Journal:  Ann Thorac Surg       Date:  1994-06       Impact factor: 4.330

Review 10.  Patient selection for left ventricular assist device therapy.

Authors:  Keith D Aaronson; Himanshu Patel; Francis D Pagani
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

View more
  5 in total

1.  Journal of Artificial Organs 2006: the year in review.

Authors:  Y Sawa; T Horiuchi; A Kishida; T Masuzawa; M Nishimura; E Tatsumi; Y Tomizawa; H Watanabe
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

2.  Thrombotic occlusion of the ascending aorta after Toyobo LVAD implantation with descending aortic perfusion in a post-Bentall patient.

Authors:  Kan Nawata; Takashi Nishimura; Shunei Kyo; Motoyuki Hisagi; Osamu Kinoshita; Aya Saito; Noboru Motomura; Shinichi Takamoto; Minoru Ono
Journal:  J Artif Organs       Date:  2010-11-06       Impact factor: 1.731

3.  Successful treatment of cerebral hemorrhage using computed tomography angiography in a patient with left-ventricular-assist device.

Authors:  Haruna Morito; Takashi Nishimura; Masahiko Ando; Osamu Kinoshita; Motoyuki Hisagi; Hideaki Imai; Akira Iijima; Noboru Motomura; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2011-10-28       Impact factor: 1.731

4.  Prediction of outcome in patients with liver dysfunction after left ventricular assist device implantation.

Authors:  Hiroyuki Nishi; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Daisuke Yoshioka; Tetsuya Saito; Shunsuke Saito; Taichi Sakaguchi; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2013-08-29       Impact factor: 1.731

Review 5.  [Veno-arterial extracorporeal membrane oxygenation. Indications, limitations and practical implementation].

Authors:  D Lunz; A Philipp; M Dolch; F Born; Y A Zausig
Journal:  Anaesthesist       Date:  2014-09       Impact factor: 1.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.